http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103467570-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff1a3cec45b03661d2188155d8826cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb19dfe86561a7365ca7e31bfed99b8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e61075e48ab37d7165fef477a481c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76fbe92543b3e708b219779b682d6dcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_361fe2646bfdecce70bfad8be968ec40 |
| publicationDate | 2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103467570-B |
| titleOfInvention | Transmembrane polypeptide with analgesic effect |
| abstract | The invention discloses a transmembrane polypeptide with an analgesic effect. The transmembrane polypeptide is any polypeptide shown in (a) to (c), wherein the amino acid sequence of the polypeptide shown in (a) is shown by amino acid residues 10 to 25 of a sequence I in a sequence table; the amino acid sequence of the polypeptide shown by (b) is shown in the sequence I in a sequence table; and the polypeptide shown by c is a derived polypeptide, which is obtained by mutating the polypeptide shown by (a) or (c) in the following manner and has the at least one effect of (1) to (3), the mutation manner comprises the steps of: replacing, deleting and/or adding one to ten of the amino acid residues 10 to 25 of the sequence I in the sequence table except for the amino acid residue 12 of the sequence 1, the effect (1) is the prevention and/or treatment of pain, the effect (2) is the disturbance of phosphorylation of actin-depolymerzing protein/cofilin, and the effect (3) is reduction of the function of transient receptor potential vanillic acid subtype 1. The transmembrane polypeptide with the analgesic effect can be used for preventing and/or treating pain. |
| priorityDate | 2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 271.